This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Stagecoach Group PLC (SGC.L) – Sees its H1 pre-tax profit climb 8% year on year. Its EPS also climbed from 12.7pp share to 13.6pp share. Its east midlands franchise has been extended to march 2018. Closing price 177.60p (Reuters)
Hammerson (HMSO.L), Intu Properties PLC (INTU.L) - Hammerson offers £3.4bn for Intu Properties and values shares in Intu at 253.9pp share. Hammerson shareholders will own 55% of issued share capital. Closing prices 534.50p, 199.00p (Bloomberg)
AstraZeneca PLC (AZN.L), GlaxoSmithKline PLC (GSK.L) - Are among more than two dozen global pharmaceuticals pledging funds in to the U.K, part of a multi-billion-pound effort to spur health-care. GSK and AZN will invest in genetic research, as much as £40m in the hunt for new medicines in part to build on a program to sequence data from 500,000 volunteers. Closing prices 1280.50p, 4727.50p (Bloomberg)
(Sources: Company Newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| CINEWORLD | CINE | -0.5% | 2.0% | -4.7% |
| FERGUSON | FERG | -1.1% | 1.8% | -2.0% |
| INTL CONSOLIDATED AIRLINES | IAG | 0.3% | 0.9% | -1.3% |
| PROVIDENT FINANCIAL | PFG | -10.2% | -6.9% | -19.9% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research